JR
Julie Rubinstein sold $1M of ADPT stock
Julie Rubinstein, President and COO of Adaptive Biotechnologies Corp (ADPT), sold 35,643 shares of ADPT stock worth $1M, per an SEC Form 4 filed Oct 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 1, 2026, 5 days before it was made public.
ADPT has moved +1.8% since the trade date, from $27.37 to $27.87 (Nov 16, 2026 close).
- Traded
- Oct 1, 2026
- Disclosed
- Oct 6, 2026
- Filing delay
- 5 days
- Price since
- +1.8%
- Role
- President and COO
- Source
- SEC Form 4